Original Research
Accepted on 02 Mar 2026
Microbiota-derived succinic acid boosts antiviral activity of AKT targeting in coronaviruses
in Antivirals and Vaccines
Original Research
Accepted on 02 Mar 2026
in Antivirals and Vaccines
Opinion
Accepted on 02 Mar 2026
in Infectious Diseases: Epidemiology and Prevention
Original Research
Accepted on 02 Mar 2026
in Dermatology
Editorial
Accepted on 02 Mar 2026
in Molecular and Cellular Pathology
Original Research
Accepted on 02 Mar 2026
in Antibiotic Resistance and New Antimicrobial drugs
Original Research
Accepted on 02 Mar 2026
in Food Microbiology
Review
Accepted on 02 Mar 2026
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 02 Mar 2026
in Microbial Vaccines
Original Research
Accepted on 02 Mar 2026
in Genitourinary Surgery and Interventions
Original Research
Accepted on 02 Mar 2026
in Intensive Care Medicine and Anesthesiology
Original Research
Accepted on 02 Mar 2026
in Endovascular and Interventional Neurology
Systematic Review
Accepted on 02 Mar 2026
in Heart Failure and Transplantation
Original Research
Accepted on 02 Mar 2026
in Obstetrics and Gynecology
Original Research
Accepted on 02 Mar 2026
in Host and Microbe Associations
Systematic Review
Accepted on 02 Mar 2026
in Gynecological Oncology
Study Protocol
Accepted on 02 Mar 2026
in Intensive Care Medicine and Anesthesiology